Literature DB >> 22162167

Terpenoids from Maytenus species and assessment of their reversal activity against a multidrug-resistant Leishmania tropica line.

María L Kennedy1, Gabriel G Llanos, Santiago Castanys, Francisco Gamarro, Isabel L Bazzocchi, Ignacio A Jiménez.   

Abstract

The phytochemical analysis of the root bark extracts of the Chilean Maytenus, M. chubutensis, and M. magellanica (Celastraceae), led to the isolation of one phenolic nortriterpene, 1, and one diterpene with a nor-ent-kaurene skeleton, 2. In addition, four known compounds were isolated, among which compound 3 has been isolated for the first time from a natural source. Their structures were elucidated by spectroscopic methods, including 1D- and 2D-NMR (COSY, ROESY, HSQC, and HMBC) experiments, comparison with data reported in the literature, and chemical correlations. The isolated compounds were assayed for their reversal activity against a multidrug-resistant Leishmania tropica line, overexpressing a P-glycoprotein related transporter. Compound 1 showed moderate multidrug-resistance reversal activity.
Copyright © 2011 Verlag Helvetica Chimica Acta AG, Zürich.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162167     DOI: 10.1002/cbdv.201000356

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  2 in total

Review 1.  Pentacyclic Triterpenoids Isolated from Celastraceae: A Focus in the 13C-NMR Data.

Authors:  Karen Caroline Camargo; Mariana Guerra de Aguilar; Acácio Raphael Aguiar Moraes; Raquel Goes de Castro; Daiane Szczerbowski; Elizabeth Luciana Marinho Miguel; Leila Renan Oliveira; Grasiely Faria Sousa; Diogo Montes Vidal; Lucienir Pains Duarte
Journal:  Molecules       Date:  2022-01-31       Impact factor: 4.411

Review 2.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.